Concomitant hepatocellular carcinoma recurrence and mantle cell lymphoma

doi:10.1016/j.hbpd.2022.06.005

摘要
图/表
参考文献(0)
相关文章 (15)

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

Abstract：Mantle cell lymphoma (MCL) is a rare subgroup of B-cell non-Hodgkin’s lymphoma (NHL) that occurs in approximately 6% of NHL patients. Chronic hepatitis and cirrhosis may promote hepatocellular carcinoma (HCC) development. Here, we report an even rarer case with coexisting HCC and MCL.

引用本文:

. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 434-437. Xue L, Wan DL, Hu C, Ke QH, Zhou J, Shen Y. Concomitant hepatocellular carcinoma recurrence and mantle cell lymphoma. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 434-437.

链接本文:

http://www.hbpdint.com/CN/10.1016/j.hbpd.2022.06.005 或 http://www.hbpdint.com/CN/Y2024/V23/I4/434

[1]	. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 331-338.
[2]	. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 339-343.
[3]	. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 344-352.
[4]	. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 353-360.
[5]	. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 361-369.
[6]	. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 370-375.
[7]	. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 376-384.
[8]	. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 385-392.
[9]	. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 393-398.
[10]	. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 399-405.
[11]	. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 406-411.
[12]	. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 412-416.
[13]	. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 417-420.
[14]	. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 421-427.
[15]	. [J]. Hepatobiliary Pancreat Dis Int, 2024, 23(4): 428-430.